These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Ventilatory Threshold and Risk of Pulmonary Exacerbations in Cystic Fibrosis. Campos NE, Vendrusculo FM, Pérez-Ruiz M, Donadio MVF. Respir Care; 2023 May; 68(5):620-627. PubMed ID: 37015814 [Abstract] [Full Text] [Related]
25. Exercise test using dry air in random adolescents: Temporal profile and predictors of bronchoconstriction. Johansson H, Norlander K, Alving K, Hedenström H, Janson C, Malinovschi A, Nordang L, Emtner M. Respirology; 2016 Feb; 21(2):289-96. PubMed ID: 26588807 [Abstract] [Full Text] [Related]
27. Diagnostic performance of the physical activity-related question of the GINA questionnaire to detect exercise-induced bronchoconstriction in asthma. Schiwe D, Heinzmann-Filho JP, Schindel CS, Gheller MF, Campos NE, Santos G, Donadio MVF, Pitrez PM. An Pediatr (Engl Ed); 2021 Jul; 95(1):40-47. PubMed ID: 34225955 [Abstract] [Full Text] [Related]
28. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. Finocchiaro G, Haddad F, Knowles JW, Caleshu C, Pavlovic A, Homburger J, Shmargad Y, Sinagra G, Magavern E, Wong M, Perez M, Schnittger I, Myers J, Froelicher V, Ashley EA. JACC Heart Fail; 2015 May; 3(5):408-418. PubMed ID: 25863972 [Abstract] [Full Text] [Related]
29. Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity. Hallstrand TS, Bates PW, Schoene RB. Chest; 2000 Nov; 118(5):1460-9. PubMed ID: 11083702 [Abstract] [Full Text] [Related]
36. Determinants of Exercise Capacity Assessed With the Modified Shuttle Test in Individuals With Cystic Fibrosis. Vendrusculo FM, Aquino ES, Campos NE, de Almeida IS, Heinzmann-Filho JP, Queiroz KCV, Leite LR, Donadio MVF. Respir Care; 2020 May; 65(5):643-649. PubMed ID: 32047118 [Abstract] [Full Text] [Related]
37. Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease. Abassi H, Gavotto A, Picot MC, Bertet H, Matecki S, Guillaumont S, Moniotte S, Auquier P, Moreau J, Amedro P. Int J Cardiol; 2019 Jun 15; 285():86-92. PubMed ID: 30857849 [Abstract] [Full Text] [Related]
38. Cardiopulmonary fitness in children with asthma versus healthy children. Moreau J, Socchi F, Renoux MC, Requirand A, Abassi H, Guillaumont S, Matecki S, Huguet H, Avesani M, Picot MC, Amedro P. Arch Dis Child; 2023 Mar 15; 108(3):204-210. PubMed ID: 36446481 [Abstract] [Full Text] [Related]
39. Prediction of mortality in adolescents with cystic fibrosis. Hulzebos EH, Bomhof-Roordink H, van de Weert-van Leeuwen PB, Twisk JW, Arets HG, van der Ent CK, Takken T. Med Sci Sports Exerc; 2014 Nov 15; 46(11):2047-52. PubMed ID: 24848493 [Abstract] [Full Text] [Related]
40. Long-term outcome of parapneumonic effusions in children: Lung function and exercise tolerance. Kontouli K, Hatziagorou E, Kyrvasilis F, Roilides E, Emporiadou M, Tsanakas J. Pediatr Pulmonol; 2015 Jun 15; 50(6):615-20. PubMed ID: 24777950 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]